Weekly Health Podcast Tackles Stroke, Crohn's, and Preterm Oxygen

The TTHealthWatch podcast reviews a new stroke therapy called loberami, which may promote neural repair after a stroke. It also examines optimal oxygen levels for preterm infants, the long-term benefits of early top-down therapy for Crohn's disease, and whether maternal consumption of eggs and peanuts affects infant allergy risk.

The stroke trial enrolled nearly 1,000 patients in China who were ineligible for clot-dissolving drugs or mechanical clot removal. They received either routine care or a 10-day intravenous course of loberamisal, a small molecule targeting two neural repair pathways. At 90 days, 70% of treated patients achieved a modified Rankin score of 0–1 (no significant disability) versus 56% in the placebo group, with no serious adverse events reported. The therapy addresses the neurodegeneration phase rather than the initial blockage, potentially expanding treatment options for late-presenting patients.

The podcast also covered a Crohn's disease study showing that early use of tumor necrosis factor inhibitors—"top-down" therapy—improved outcomes up to five years, with no major downsides. Another segment examined oxygen targets for preterm infants born at 32–35 weeks, noting that many were not initially hypoxic but still required ongoing respiratory support. Finally, a maternal diet study found that consuming eggs and peanuts during pregnancy did not reduce infant allergy risk, though one-third of participants dropped out.